[HTML][HTML] A systematic literature review of the epidemiology, health-related quality of life impact, and economic burden of immunoglobulin A nephropathy
CS Kwon, P Daniele, A Forsythe… - Journal of Health …, 2021 - ncbi.nlm.nih.gov
Introduction: This systematic literature review analyzed published evidence on IgA
nephropathy (IgAN), focusing on US epidemiology, health-related quality of life (HRQoL) …
nephropathy (IgAN), focusing on US epidemiology, health-related quality of life (HRQoL) …
Long-term outcomes of patients with IgA nephropathy in the German CKD cohort
E Stamellou, J Nadal, B Hendry, A Mercer… - Clinical kidney …, 2024 - academic.oup.com
Background The importance of albuminuria as opposed to proteinuria in predicting kidney
outcomes in primary immunoglobulin A nephropathy (IgAN) is not well established. Methods …
outcomes in primary immunoglobulin A nephropathy (IgAN) is not well established. Methods …
Long-term outcomes of patients with IgA nephropathy categorized by the International IgAN risk prediction tool and by the degree of hematuria at diagnosis
R Ebbestad, M Sanaei Nurmi, S Lundberg - Nephron, 2022 - karger.com
Abstract Introduction: Within 30 years, 20–50% of IgA nephropathy (IgAN) patients progress
to end-stage kidney disease (ESKD). Identifying these patients can be difficult since renal …
to end-stage kidney disease (ESKD). Identifying these patients can be difficult since renal …
Long term outcome of immunoglobulin A (IgA) nephropathy: A single center experience
R Mohd, NE Mohammad Kazmin, R Abdul Cader… - PLoS …, 2021 - journals.plos.org
Introduction IgA nephropathy (IgAN) has a heterogeneous presentation and the progression
to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as …
to end stage renal disease (ESRD) is often influenced by demographics, ethnicity, as well as …
Epidemiology and risk factors for progression in Chinese patients with IgA nephropathy
Y Liu, W Wei, C Yu, L Xing, M Wang, R Liu, J Ma, X Liu… - Medicina clinica, 2021 - Elsevier
Abstract Background IgA nephropathy (IgAN) is one of the main causes of primary
glomerulonephritis worldwide, and it is also the main primary disease leading to chronic …
glomerulonephritis worldwide, and it is also the main primary disease leading to chronic …
External validation of the international prognosis prediction model of IgA nephropathy
L Hu, Y Fang, J Huang, J Liu, L Xu, W He - Renal Failure, 2024 - Taylor & Francis
Abstract Background The International IgA Nephropathy (IgAN) Network developed and
validated two prognostic prediction models for IgAN, one incorporating a race parameter …
validated two prognostic prediction models for IgAN, one incorporating a race parameter …
Systematic review of the application of the Kidney Failure Risk Equation and Oxford classification in estimating prognosis in IgA Nephropathy
MP Toal, R Fergie, MP Quinn, CJ Hill, C O'Neill… - Systematic …, 2025 - Springer
Abstract Background IgA nephropathy (IgAN) is the most common primary
glomerulonephritis in the world and is an important cause of chronic kidney disease (CKD) …
glomerulonephritis in the world and is an important cause of chronic kidney disease (CKD) …
Drugs in Development to Treat IgA Nephropathy
L Del Vecchio, M Allinovi, S Comolli, S Peiti, C Rimoldi… - Drugs, 2024 - Springer
IgA nephropathy is a common glomerulonephritis consequent to the autoimmune response
to aberrant glycosylated immunoglobulin (Ig) A antibodies. Although it has historically been …
to aberrant glycosylated immunoglobulin (Ig) A antibodies. Although it has historically been …
Lifetime progression of IgA nephropathy: a retrospective cohort study with extended long-term follow-up
M Rivedal, OP Nordbø, YL Haaskjold, R Bjørneklett… - BMC nephrology, 2025 - Springer
Abstract Background IgA nephropathy (IgAN) exhibits an unpredictable trajectory, creating
difficulties in prognostication, monitoring, treatment, and research planning. This study …
difficulties in prognostication, monitoring, treatment, and research planning. This study …